Bone sialoprotein (BSP) is an acidic, non-collagenous protein specific to bone proposed previously to promote hydroxyapatite (HAP) nucleation and modulate HAP nanocrystal growth. Specifically, two phosphorylated acidic amino acid sequences in BSP, highly conserved across several vertebrates, are the proposed active sites. We selected one of these sites, i.e. (Sp)2E8, where Sp represents a phosphoserine as a model peptide to study the role of BSP. We used molecular dynamics simulations to determine whether an α-helix or a random coil peptide conformation promotes templated HAP nucleation. A bioinformatics method helps infer preferential crystal growth directions by predicting the likely peptide conformations adsorbed on the (001), (100), and (110) crystal faces of HAP. Results suggest that, independent of conformation, no stable nucleating template is formed and, thus, the ion distributions in the vicinity of the peptide that eventually lead to a stable nucleus start out with disordered arrangements of ions. When adsorbed on all three faces, the Sp residues bind strongly regardless of the peptide conformation, and the Glu residues show different propensities to form helical conformations. The lack of geometrical templating between the peptide residues and all HAP surface sites indicates that adsorption and subsequent crystal growth modulation may be structurally nonspecific.

Keywords:
Bone sialoprotein, Biomineralization, Nucleation, Adsorption, Hydroxyapatite, Computational simulation
1.
Addadi, L., S. Weiner (1985) Interactions between acidic proteins and crystals – stereochemical requirements in biomineralization. Proc Natl Acad Sci USA 82: 4110–4114.
2.
Alford, A.I., K.D. Hankenson (2006) Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration. Bone 38: 749–757.
3.
Bertinetti, L., C. Drouet, C. Combes, C. Rey, A. Tampieri, S. Coluccia, G. Martra (2009) Surface characteristics of nanocrystalline apatites: effect of Mg surface enrichment on morphology, surface hydration species, and cationic environments. Langmuir 25: 5647–5654.
4.
Boskey, A.L. (1995) Osteopontin and related phosphorylated sialoproteins – effects on mineralization. Ann NY Acad Sci 760: 249–256.
5.
Boskey, A.L. (1999) Phosphoproteins and biomineralization. Phosphorus Sulfur Silicon Relat Elem 146: 189–192.
6.
Boskey, A.L. (2000) Bone mineralization; in Cowin S.C. (ed): Bone Mechanics Handbook, ed 2. Boca Raton, CRC Press,5.1–5.31.
7.
Boskey, A.L. (2003) Biomineralization: an overview. Connect Tissue Res 44:5–9.
8.
Brooks, B.R., C.L. Brooks, A.D. Mackerell, L. Nilsson, R.J. Petrella, B. Roux, Y. Won, G. Archontis, C. Bartels, S. Boresch, A. Caflisch, L. Caves, Q. Cui, A.R. Dinner, M. Feig, S. Fischer, J. Gao, M. Hodoscek, W. Im, K. Kuczera, T. Lazaridis, J. Ma, V. Ovchinnikov, E. Paci, R.W. Pastor, C.B. Post, J.Z. Pu, M. Schaefer, B. Tidor, R.M. Venable, H.L. Woodcock, X. Wu, W. Yang, D.M. York, M. Karplus (2009) CHARMM: the biomolecular simulation program. J Comput Chem 30: 1545–1614.
9.
Brooks, B.R., R.E. Bruccoleri, B.D. Olafson, D.J. States, S. Swaminathan, M. Karplus (1983) CHARMM – a program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 4: 187–217.
10.
Ecarotcharrier, B., F. Bouchard, C. Delloye (1989) Bone sialoprotein II synthesized by cultured osteoblasts contains tyrosine sulfate. J Biol Chem 264: 20049–20053.
11.
Fisher, L.W., O.W. McBride, J.D. Termine, M.F. Young (1990) Human bone sialoprotein: deduced protein sequence and chromosomal localization. J Biol Chem 265: 2347–2351.
12.
Fisher, L.W., D.A. Torchia, B. Fohr, M.F. Young, N.S. Fedarko (2001) Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 280: 460–465.
13.
Franzen, A., D. Heinegard (1985) Isolation and characterization of 2 sialoproteins present only in bone calcified matrix. Biochem J 232: 715–724.
14.
Ganss, B., R.H. Kim, J. Sodek (1999) Bone sialoprotein. Crit Rev Oral Biol Med 10: 79–98.
15.
George, A., A. Veis (2008) Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition. Chem Rev 108: 4670–4693.
16.
Glimcher, M.J. (2006) Bone: nature of the calcium phosphate crystals and cellular, structural, and physical chemical mechanisms in their formation: Rev Mineral Geochem, pp 223–282.
17.
Goldberg, H.A., G.K. Hunter (1994) Nucleation of hydroxyapatite by bone sialoprotein: role of glutamate-rich sequences. J Dent Res 73: 282–282.
18.
Goldberg, H.A., K.J. Warner, M.J. Stillman, G.K. Hunter (1996) Determination of the hydroxyapatite-nucleating region of bone si-aloprotein. Connect Tissue Res 35: 385–392.
19.
Gorski, J.P. (1992) Acidic phosphoproteins from bone-matrix: a structural rationalization of their role in biomineralization. Calcif Tissue Int 50: 391–396.
20.
Hunter, G.K., H.A. Goldberg (1994) Modulation of crystal formation by bone phosphoproteins: role of glutamic acid-rich sequences in the nucleation of hydroxyapatite by bone sialoprotein. Biochem J 302: 175–179.
21.
Jaeger, C., S. Maltsev, A. Karrasch (2006) Progress of structural elucidation of amorphous calcium phosphate (ACP) and hydroxyapatite (HAp): disorder and surfaces as seen by solid state NMR. Key Eng Mater 309–311: 69–72.
22.
MacKerell, A.D., D. Bashford, M. Bellott, R.L. Dunbrack, J.D. Evanseck, M.J. Field, S. Fischer, J. Gao, H. Guo, S. Ha, D. Joseph-McCarthy, L. Kuchnir, K. Kuczera, F.T.K. Lau, C. Mattos, S. Michnick, T. Ngo, D.T. Nguyen, B. Prodhom, W.E. Reiher, B. Roux, M. Schlenkrich, J.C. Smith, R. Stote, J. Straub, M. Watanabe, J. Wiorkiewicz-Kuczera, D. Yin, M. Karplus (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102: 3586–3616.
23.
Makrodimitris, K., D.L. Masica, E.T. Kim, J.J. Gray (2007) Structure prediction of protein-solid surface interactions reveals a molecular recognition motif of statherin for hydroxyapatite. J Am Chem Soc 129: 13713–13722.
24.
Mann, S. (2001) Biomineralization: Principles and Concepts in Bioinorganic Materials Chemistry. New York, Oxford University Press.
25.
Masica, D.L., J.J. Gray (2009) Solution- and adsorbed-state structural ensembles predicted for the statherin-hydroxyapatite system. Biophys J 96: 3082–3091.
26.
Masica, D.L., S.B. Schrier, E.A. Specht, J.J. Gray (2010) De novo design of peptide-calcite biomineralization systems. J Am Chem Soc 132: 12252–12262.
27.
Saad, F.A., E. Salih, L. Wunderlich, R. Fluckiger, M.J. Glimcher (2005) Prokaryotic expression of bone sialoprotein and identification of casein kinase II phosphorylation sites. Biochem Bioph Res Commun 333: 443–447.
28.
Salih, E. (2003) In vivo and in vitro phosphorylation regions of bone sialoprotein. Connect Tissue Res 44: 223–229.
29.
Salih, E., H.Y. Zhou, M.J. Glimcher (1996) Phosphorylation of purified bovine bone sialoprotein and osteopontin by protein kinases. J Biol Chem 271: 16897–16905.
30.
Shapiro, H.S., J.K. Chen, J.L. Wrana, Q. Zhang, M. Blum, J. Sodek (1993) Characterization of porcine bone sialoprotein: primary structure and cellular expression. Matrix 13: 431–440.
31.
Shimabayashi, S., C. Tamura, M. Nakagaki (1981) Adsorption of hydroxyl ion on hydroxyapatite. Chem Pharm Bull 29: 3090–3098.
32.
Sorensen, E.S., P. Hojrup, T.E. Petersen (1995) Posttranslational modifications of bovine osteopontin: identification of 28 phosphorylation and 3 O-glycosylation sites. Protein Sci 4: 2040–2049.
33.
Steele, D.G., C.A. Bramblett (1988) The Anatomy and Biology of the Human Skeleton. College Station, Texas A&M University Press.
34.
Tye, C.E., K.R. Rattray, K.J. Warner, J.A.R. Gordon, J. Sodek, G.K. Hunter, H.A. Goldberg (2003) Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein. J Biol Chem 278: 7949–7955.
35.
Yang, Y., Q. Cui, N. Sahai (2010) How does bone sialoprotein promote the nucleation of hydroxyapatite? A molecular dynamics study using model peptides of different conformations. Langmuir 26: 9848–9859.
36.
Zaia, J., R. Boynton, D. Heinegard, F. Barry (2001) Posttranslational modifications to human bone sialoprotein determined by mass spectrometry. Biochemistry 40: 12983–12991.
37.
Zhu, X.L., B. Ganss, H.A. Goldberg, J. Sodek (2001) Synthesis and processing of bone sialoproteins during de novo bone formation in vitro. Biochem Cell Biol 79: 737–746.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.